Search results for "PARKIN"

showing 10 items of 468 documents

Pattern of brain destruction in Parkinson's and Alzheimer's diseases

1996

Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common age-related degenerative disorders of the human brain. Both diseases involve multiple neuronal systems and are the consequences of cytoskeletal abnormalities which gradually develop in only a small number of neuronal types. In AD, susceptible neurons produce neurofibrillary tangles (NFTs) and neuropil threads (NTs), while in PD, they develop Lewy bodies (LBs) and Lewy neurites (LNs). The specific lesional pattern of both illnesses accrues slowly over time and remains remarkably consistent across cases. In AD, six developmental stages can be distinguished on account of the predictable manner in which the neurofibrillar…

AgingPathologymedicine.medical_specialtyParkinson's diseaseModels NeurologicalLimbic systemAlzheimer DiseaseLimbic SystemmedicineHumansBiological PsychiatryNeocortexLewy bodyBrainParkinson DiseaseNeurofibrillary tangleHuman brainmedicine.diseasePsychiatry and Mental healthmedicine.anatomical_structurenervous systemNeurologyCerebral cortexLewy neuriteNeurology (clinical)PsychologyNeuroscienceJournal of Neural Transmission
researchProduct

Quantifying Dynamic Balance in Young, Elderly and Parkinson's Individuals: A Systematic Review

2018

Introduction: Falling is one of the primary concerns for people with Parkinson's Disease and occurs predominately during dynamic movements, such as walking. Several methods have been proposed to quantify dynamic balance and to assess fall risk. However, no consensus has been reached concerning which method is most appropriate for examining walking balance during unperturbed and perturbed conditions, particularly in Parkinson's Disease individuals. Therefore, this systematic review aimed to assess the current literature on quantifying dynamic balance in healthy young, elderly and Parkinson's individuals during unperturbed and perturbed walking. Methods: The PubMed database was searched by ti…

Agingmedicine.medical_specialtyParkinson's diseaseCognitive Neurosciencelcsh:RC321-57103 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationperturbationsfallsmedicineElderly adultsDynamic balanceMethodological qualitylcsh:Neurosciences. Biological psychiatry. Neuropsychiatrydynamic balanceWalking balance030229 sport sciencesFall riskCenter of gravitywalking stabilityDetrended fluctuation analysisSystematic ReviewPsychology030217 neurology & neurosurgeryNeuroscienceFrontiers in Aging Neuroscience
researchProduct

Pain perception in Parkinson's disease: A systematic review and meta-analysis of experimental studies

2017

While hyperalgesia (increased pain sensitivity) has been suggested to contribute to the increased prevalence of clinical pain in Parkinson's disease (PD), experimental research is equivocal and mechanisms are poorly understood. We conducted a meta-analysis of studies comparing PD patients to healthy controls (HCs) in their response to experimental pain stimuli. Articles were acquired through systematic searches of major databases from inception until 10/2016. Twenty-six studies met inclusion criteria, comprising 1292 participants (PD = 739, HCs = 553). Random effects meta-analysis of standardized mean differences (SMD) revealed lower pain threshold (indicating hyperalgesia) in PD patients d…

Agingmedicine.medical_specialtyParkinson's diseaseDopamineAnalgesicDopaminaStimulationDiseaseBiochemistry03 medical and health sciences0302 clinical medicinesystematic reviewDopamineInternal medicineThreshold of painmedicineHumanspain030212 general & internal medicineMolecular Biologybusiness.industryPain PerceptionParkinson DiseaseParkinson’s disease Dopamine Pain Meta-analysis Systematic reviewmedicine.diseasemeta-analysisNeurologyHyperalgesiaMeta-analysisHyperalgesiaPhysical therapyParkinson’s diseaseDoença de Parkinsonmedicine.symptomdopaminebusiness030217 neurology & neurosurgeryBiotechnologymedicine.drug
researchProduct

Cholesterol facilitates interactions between α‐synuclein oligomers and charge‐neutral membranes

2015

AbstractOligomeric species formed during α-synuclein fibrillation are suggested to be membrane-disrupting agents, and have been associated with cytotoxicity in Parkinson’s disease. The majority of studies, however, have revealed that the effect of α-synuclein oligomers is only noticeable on systems composed of anionic lipids, while the more physiologically relevant zwitterionic lipids remain intact. We present experimental evidence for significant morphological changes in zwitterionic membranes containing cholesterol, induced by α-synuclein oligomers. Depending on the lipid composition, model membranes are either unperturbed, disrupt, or undergo dramatic morphological changes and segregate …

AmyloidParkinson's diseaseFluorescent DyeBiophysicsPlasma protein bindingBiochemistryOligomerProtein Structure SecondaryMultiphoton microscopyMembrane phase separationCell membranechemistry.chemical_compoundGeneticStructural Biology2-NaphthylamineLaurdan fluorescenceGeneticsFluorescence microscopemedicineMolecular BiologyFluorescent DyesLaurateα-SynucleinMembranesChemistryMedicine (all)2-NaphthylamineCell MembraneMembraneCell BiologySettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)CholesterolMembranemedicine.anatomical_structureBiophysicBiochemistryStructural biologyOligomeralpha-SynucleinParkinson’s diseaseProtein MultimerizationLaurdanLauratesProtein BindingFEBS Letters
researchProduct

STUDIO DELL’INDIVIDUAZIONE DEL PARKINSON TRAMITE ANALISI DELLE CARATTERISTICHE VOCALI ATTRAVERSO METODI DI OTTIMIZAZIONE STOCASTICA

Analisi vocaleHealth careParkinsonSettore ING-INF/01 - Elettronica
researchProduct

Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.

2009

Strong evidence indicates that oxidative stress may be causally involved in the pathogenesis of Parkinson's disease. We have employed human dopaminergic neuroblastoma cells and rat primary mesencephalic neurons to assess the protective potential of three novel bisarylimine antioxidants on dopaminergic cell death induced by complex I inhibition or glutathione depletion. We have found that exceptionally low concentrations (EC(50) values approximately 20 nM) of these compounds (iminostilbene, phenothiazine, and phenoxazine) exhibited strong protective effects against the toxicities of MPP(+), rotenone, and l-buthionine sulfoximine. Investigating intracellular glutathione levels, it was found t…

Antioxidantmedicine.medical_treatmentDopamineGlutathione reductaseNeurotoxinsBiologymedicine.disease_causeProtein oxidationBiochemistryAntioxidantsLipid peroxidationRats Sprague-DawleyCellular and Molecular Neurosciencechemistry.chemical_compoundCell Line TumormedicineAnimalsHumansCells CulturedMembrane Potential MitochondrialCell DeathDose-Response Relationship DrugNeurotoxicityParkinson DiseaseRotenoneGlutathionemedicine.diseaseGlutathioneMitochondriaRatsSubstantia NigraOxidative StressNeuroprotective AgentschemistryBiochemistryElectron Transport Chain Complex ProteinsCytoprotectionNerve DegenerationIminesOxidation-ReductionOxidative stressJournal of neurochemistry
researchProduct

Neuronal cell cycle: the neuron itself and its circumstances.

2015

Neurons are usually regarded as postmitotic cells that undergo apoptosis in response to cell cycle reactivation. Nevertheless, recent evidence indicates the existence of a defined developmental program that induces DNA replication in specific populations of neurons, which remain in a tetraploid state for the rest of their adult life. Similarly, de novo neuronal tetraploidization has also been described in the adult brain as an early hallmark of neurodegeneration. The aim of this review is to integrate these recent developments in the context of cell cycle regulation and apoptotic cell death in neurons. We conclude that a variety of mechanisms exists in neuronal cells for G1/S and G2/M check…

ApoptosisBrdU 5-bromo-2′-deoxyuridineReviewp75NTR neurotrophin receptor p75Nervous SystemG0 quiescent stateCKI Cdk-inhibitorNeuronsCell DeathNeurodegenerationCell CycleapoptosisNeurodegenerative DiseasesCell cycleCell biologymedicine.anatomical_structureInk inhibitor of kinaseBDNF brain-derived neurotrophic factorp38MAPK p38 mitogen-activated protein kinaseG2 growth phase 2Programmed cell deathS-phasePD Parkinson diseaseRb RetinoblastomaMcm2 minichromosome maintenance 2PCNA proliferating cell nuclear antigenMitosisContext (language use)BiologyCdk cyclin-dependent kinaseCNS central nervous systemS-phase synthesis phase.Cip/Kip cyclin inhibitor protein/kinase inhibitor proteinmedicineAnimalsHumansMolecular BiologyMitosisTetraploidAD Alzheimer diseasecell cycle re-entryDNA replicationCell BiologyNeuronmedicine.diseaseG1 growth phase 1neuronRGCs retinal ganglion cellsCell cycle re-entrytetraploidnervous systemApoptosisNeuronDevelopmental BiologyCell cycle (Georgetown, Tex.)
researchProduct

Driving impairment and crash risk in Parkinson disease: A systematic review and meta-analysis

2018

ObjectivesTo provide the best possible evidence base for guiding driving decisions in Parkinson disease (PD), we performed a meta-analysis comparing patients with PD to healthy controls (HCs) on naturalistic, on-the-road, and simulator driving outcomes.MethodsSeven major databases were systematically searched (to January 2018) for studies comparing patients with PD to HCs on overall driving performance, with data analyzed using random-effects meta-analysis.ResultsFifty studies comprising 5,410 participants (PD = 1,955, HC = 3,455) met eligibility criteria. Analysis found the odds of on-the-road test failure were 6.16 (95% confidence interval [CI] 3.79–10.03) times higher and the odds of sim…

Automobile Drivingmedicine.medical_specialtyMEDLINECrashDiseasemeta-analysiOdds03 medical and health sciences0302 clinical medicineInternal medicinedrivingHumansMedicine030212 general & internal medicinecrashesbusiness.industryAccidents TrafficneurodegenerationParkinson DiseaseCrash riskOdds ratioDatabases Bibliographicfitness to driveConfidence intervalMeta-analysisParkinson’s diseaseNeurology (clinical)Psychomotor Disordersbusiness030217 neurology & neurosurgery
researchProduct

Impaired circadian heart rate variability in Parkinson’s disease: a time-domain analysis in ambulatory setting

2020

Abstract Background Heart rate variability (HRV) decreases in Parkinson’s disease (PD) and it can be considered a marker for cardiovascular dysautonomia. The purpose of this pilot study is to evaluate long-term time-domain analysis of HRV of PD patients and compare the results with those of matched healthy individuals. Methods Idiopathic PD patients without comorbidity impairing HRV, and age-matched healthy individuals were recruited in a pilot study. A long-term time domain analysis of HRV using 24-h ambulatory ECG was performed. Results Overall, 18 PD patients fulfilling inclusion criteria completed the evaluation (mean age was 55.6 ± 8.8, disease duration: 5.0 ± 4.7). Mean SCOPA-AUT scor…

Autonomic disordersmedicine.medical_specialtyParkinson's diseaseNeurologyAutonomic disorderPopulationPilot ProjectsNon-motor symptomsPrimary DysautonomiasAutonomic disorderlcsh:RC346-429Antiparkinson AgentsLevodopaHeart RateInternal medicinemedicineHumansHeart rate variabilityeducationlcsh:Neurology. Diseases of the nervous systemAgededucation.field_of_studybusiness.industryDysautonomiaParkinson DiseaseGeneral MedicineMiddle Agedmedicine.diseaseComorbidityCircadian RhythmHeart rate variability SCOPA-AUTCardiovascular DiseasesAmbulatoryCardiologyNeurology (clinical)medicine.symptombusinessResearch ArticleBMC Neurology
researchProduct

Effect of Foot Orthoses and Shoes in Parkinson's Disease Patients : A PRISMA Systematic Review

2021

[Abstract] Reduced plantar foot sensation, postural instability, and gait difficulties are characteristic of Parkinson´s disease patients. A systematic review was carried out to determine the effect of the different types of insoles and shoes in these patients. Several databases were used to search for relevant articles reporting Parkinson´s disease patients undergoing treatment with any type of insole and footwear. All titles and abstracts were reviewed independently by two reviewers and the available data were extracted. The study eligibility criteria were any type of experimental study that included Parkinson’s disease patients treated with any type of insole or footwear. Eight studies w…

Balancemedicine.medical_specialtyPasoParkinson's diseasePostural instabilityMedicine (miscellaneous)EquilibrioReviewControlled studiesinsolegaitFootwearInsolePhysical medicine and rehabilitationSensationmedicineFoot OrthosesGaitBalance (ability)PlantillaImportant conclusionbusiness.industryRbalancemedicine.diseaseGaitParkinson diseaseExtremitatsPodologíaCalzadoEnfermedad de ParkinsonfootwearParkinson’s diseaseMedicineSistema nerviós Malaltiesbusiness
researchProduct